abrdn Inc.
Philadelphia, Pennsylvaniaaberdeeninvestments.com
Overview
abrdn Inc. is a United States-based investment adviser and a subsidiary of Aberdeen Group plc, a global specialist asset manager providing strategies in credit, real assets, and specialist equities.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Third Arc Bio | Feb 2026 | Series A Extension | Co-investor |
| Veradermics Inc. | Oct 2025 | Series C | Co-investor |
| Crystalys Therapeutics | Sep 2025 | Series A | Co-investor |
| Glycomine | Apr 2025 | Series C | Lead |
| Arbor Biotechnologies | Mar 2025 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.